The rollout of Elsa, the Food and Drug Administration’s new generative AI tool, “marks the dawn of the AI era at the FDA,” according to Jeremy Walsh, the agency’s chief AI officer.
FDA Commissioner Marty Makary announced Elsa’s launch on Wednesday noting it was initially set for 30...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?